Venrock, formerly known as Venrock Associates, is a venture capital firm founded in 1969 by Laurance Rockefeller as the investment arm of the Rockefeller family. Headquartered in Palo Alto, California, with an office in New York City, it focuses on early-stage investments in healthcare, biotechnology, information technology, and emerging technologies.
The firm has invested over $2.5 billion in more than 440 companies, leading to 125 IPOs and notable exits including Intel, Apple, Gilead Sciences, Illumina, and Check Point Software. In healthcare and life sciences, portfolio companies encompass Juno Therapeutics, Millennium Pharmaceuticals, and recently Kelonia Therapeutics, a biotech developing in vivo CAR-T therapies which Venrock incubated and seed-funded.
While primarily active in tech and biotech, Venrock has supported innovations touching energy and materials sectors, such as Nanosys and DuPont's nanotech division.
